RxDoctor Payments Data

Dudley Phipps

Surgical · Des Moines, IANPI 1306807714

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $114,294 of the $172,548 with a category attached, or 66.2%. Amgen accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among surgical clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$172,548in general payments, 2019–2025

Across 365 payments — averaging $472.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$172K
  • AstraZeneca$119

What the payments were for

  • Consulting fees$3,7502%
  • Speaking & faculty fees$114,29466%
  • Travel & lodging$48,52428%
  • Food & beverage$5,9803%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen364$172,429
AstraZeneca1$119

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$172,548 in reported general payments places this provider in the 95th percentile of 49 surgical providers in Iowa.

See all surgical providers in Iowa →

Other surgical in Des Moines

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →